Deepa Nath Selected Research

Enzymes

5/2002

Engineering N-terminal domain of tissue inhibitor of metalloproteinase (TIMP)-3 to be a better inhibitor against tumour necrosis factor-alpha-converting enzyme.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Deepa Nath Research Topics

Disease

3	Neoplasms (Cancer) 01/2023 - 01/2023
2	Carcinoma (Carcinomatosis) 01/2023 - 01/2021
1	Tuberculosis (Tuberculoses) 01/2023
1	Hemorrhoids 01/2023
1	Hepatocellular Carcinoma (Hepatoma) 01/2023
1	Inflammation (Inflammations) 01/2023
1	Liver Neoplasms (Liver Cancer) 01/2023
1	Lung Neoplasms (Lung Cancer) 01/2023
1	Disease Progression 01/2023
1	Necrosis 05/2002

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2021
1	Irritants (Vesicants)IBA 01/2023
1	AcetoneIBA 01/2023
1	Caspase 3 (Caspase-3)IBA 01/2023
1	PhytochemicalsIBA 01/2023
1	acteosideIBA 01/2023
1	FlavonoidsIBA 01/2023
1	TNF Receptor-Associated Factor 2 (TRAF2)IBA 01/2021
1	desmethylastemizoleIBA 01/2021
1	Flupenthixol (Flupentixol)IBA 01/2021
1	Tissue Inhibitor of Metalloproteinase-3IBA 05/2002
1	ADAM17 ProteinIBA 05/2002
1	EnzymesIBA 05/2002
1	Tissue Inhibitor of MetalloproteinasesIBA 05/2002

Therapy/Procedure

2	Therapeutics 01/2023 - 01/2023
1	Traditional Medicine (Folk Remedies) 01/2023